Lobbyist Insight

Colorado

SB18-129

Reorganize Drugs & Medical Devices Sales Tax Exemption

Read SB18-129 at the Colorado legislature →

13 registered positions on this bill · 13 state a side.

Lobbyist or firmFor clientPositionSession
FRITTS, KELLI LAARPMonitoring2017-2018
Colorado Legislative StrategiesAMGENMonitoring2017-2018
McGihon, AnneAllergan, Inc.Monitoring2017-2018
REES CONSULTING AND PUBLIC AFFAIRSAllergan, Inc.Monitoring2017-2018
REES CONSULTING AND PUBLIC AFFAIRSCentura HealthMonitoring2017-2018
Orf & Orf P.C.Colorado Hearing SocietyMonitoring2017-2018
Orf & Orf PCColorado Hearing SocietyMonitoring2017-2018
Solem, JoanELI LILLY PHARMACEUTICAL COMPANYMonitoring2017-2018
Capitol Focus, LLCGLAXOSMITHKLINEMonitoring2017-2018
Capitol Focus, LLCGenentech, A member of the Roche GroupMonitoring2017-2018
Capitol Focus, LLCJohnson & JohnsonMonitoring2017-2018
YOUNG, Bradley Young J.RX PLUS PHARMACIES, INC.Monitoring2017-2018
Capitol Focus, LLCUCB, Inc.Monitoring2017-2018

Positions are as filed. A lobbyist may file more than once as a position changes.